AZD0486 Clinical Trials

3 actively recruiting trials across 2 locations

Also known as: Surovatamig, TNB-486

Pipeline

Phase 3: 1Phase 1/2: 2

Top Sponsors

AstraZeneca3

Indications

Cancer3
Large B-cell Lymphoma2
B Cell Acute Lymphoblastic Leukemia (B-ALL)1
Chronic Lymphocytic Leukaemia1
Small Lymphocytic Lymphoma1

Other1 trial

AZD0486 1L Therapy for Elderly or Unfit Participants With LBCL

Phase 3

Birmingham, Alabama1 trial

AZD0486 as Monotherapy in B-cell Acute Lymphoblastic Leukaemia

Research Site

Phase 1/2

Boston, Massachusetts1 trial

A Study of AZD0486 Monotherapy or in Combination With Other Anti-Cancer Agents for Mature B-Cell Malignancies

Research Site

Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.